[[bpstrwcotob]]


Designing Life Sciences Real Estate for Growth and Talent

Designing Life Sciences Real Estate for Growth and Talent

As life sciences companies evolve and competition for talent intensifies, developers are rethinking laboratory campuses with adaptable infrastructure, faster occupancy, and employee-focused environments

Read More
What the Life Sciences Market Means for Your Next Lab

What the Life Sciences Market Means for Your Next Lab

In a rapidly evolving life sciences market, designing for change may be the most important investment a lab owner can make

Read More
Professional Profile: Mark Seliskar

Professional Profile: Mark Seliskar

Lab Design News spoke to Mark Seliskar, head of life sciences operations in Canada at JLL, about how his career in life sciences facilities management has shaped his approach to multi-tenant operations, the importance of designing flexible, expansion-ready laboratory spaces, and the growing role of AI-enabled capabilities in future facility partnerships

Read More
A Major First Step in a Decade-Long Vision

A Major First Step in a Decade-Long Vision

Construction has begun on Project GB1 at Norwich Research Park in the UK, a flexible 63,000-sf lab and office building marking the start of a £200+ million, 10-year expansion to support growth in agri-food, health, and environmental sciences

Read More
Understanding Key Cost Drivers for Lab Construction Projects in 2026 and Beyond

Understanding Key Cost Drivers for Lab Construction Projects in 2026 and Beyond

Lab construction costs are driven largely by complex MEP systems, specialized design and equipment, regulatory and sustainability requirements, and location factors, with prices expected to continue rising due to material costs and trade policies

Read More
Life Sciences Real Estate: Adjusting to a More Disciplined Market
Real estate, Business News, Features MaryBeth DiDonna Real estate, Business News, Features MaryBeth DiDonna

Life Sciences Real Estate: Adjusting to a More Disciplined Market

After a period of rapid expansion and correction, the US life sciences real estate market is beginning to stabilize in a tenant-favored environment, with recovery led by major biotech hubs and demand increasingly concentrated in high-quality, purpose-built lab spaces that meet the specific needs of established pharmaceutical companies and emerging AI-driven biotech firms

Read More